言語 |
英語
|
著者 |
Shigematsu Takashi
Department of Nephrology, Wakayama Medical University, 811-1 Kimiidera, Wakayama-City, Wakayama, 641-8509, Japan
Muraoka Ryoichi
Data Science Group, Clinical Development Department, EA Pharma Co., Ltd, Tokyo, Japan
Nishizawa Yoshiki
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan
|
主題 | Chronic kidney disease (CKD); Bone disease; Osteoporosis; Biomarkers; Calcium; Treatment
|
掲載誌名 |
BMC NEPHROLOGY
|
巻 | 18
|
ISSN | 1471-2369
|
発行日 | 2017-02-15
|
DOI | |
PubMed ID | |
出版者 | BIOMED CENTRAL LTD
|
資料タイプ |
学術雑誌論文
|
部局 |
医学部
|
備考 | This study was supported by the Joint Development Program of EA Pharma Co., Ltd. and Takeda Pharmaceutical Co., Ltd. Funding for writing/editorial support was provided by EA Pharma Co., Ltd.
|